Curegenix

United States
Chester, Vermont, United States, 94010

Company profile

Curegenix company profile

Curegenix is a medication research firm in the clinical stage. It focused on the development of new small-molecule chemical drugs for the treatment of tumors and organ fibrosis. They are developing novel drugs targeting the WNT signaling pathway for cancer and tissue repair and regeneration.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
94010
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Series Unknown / 2016-04-04
Last equity funding
Series Unknown
Investors
1
Founders
1

Founders and investors

Founders

Songzhu An

Investors

Eight Roads Ventures